Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 157

Results For "president"

1715 News Found

ISA celebrates October as stroke awareness month
Healthcare | October 21, 2021

ISA celebrates October as stroke awareness month

India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50


Global Heart Hub and Novartis partner to tackle ASCVD
Public Health | October 21, 2021

Global Heart Hub and Novartis partner to tackle ASCVD

Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease (ASCVD) care


HCL Tech and Innovaccer collaborate to scale up digital health transformation
Digitisation | October 20, 2021

HCL Tech and Innovaccer collaborate to scale up digital health transformation

By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance


Medtronic announces launch of Open Innovation Platform for APAC
Digitisation | October 20, 2021

Medtronic announces launch of Open Innovation Platform for APAC

The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology


AstraZeneca India opens clinical data and insights division
News | October 20, 2021

AstraZeneca India opens clinical data and insights division

The division is expected to grow to over a 100-member strong team by 2022


Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %
Biotech | October 19, 2021

Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %

The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit


Imfinzi plus tremelimumab significantly improved overall survival in liver cancer
Biotech | October 18, 2021

Imfinzi plus tremelimumab significantly improved overall survival in liver cancer

The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib


Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline
Biotech | October 18, 2021

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline

Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme


Exelixis in-licenses second anti-cancer compound from Aurigene
Biotech | October 15, 2021

Exelixis in-licenses second anti-cancer compound from Aurigene

U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma


HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
Digitisation | October 12, 2021

HCL expands its partnership with Google Cloud to focus on healthcare and life sciences

HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs